United Therapeutics Corporation (UTHR) Rating Reiterated by Oppenheimer Holdings, Inc.


's stock had its "buy" rating reiterated by stock analysts at Oppenheimer Holdings, Inc. in a research note issued to investors on Tuesday. A number of other brokerages have also recently issued reports on UTHR.



from Biotech News